See Liz Spikol for details, and this great conversation on her blog for background. Also check out her first two video posts on YouTube.
Advertisements
Colophon
Subscribe
Disclaimer
Not responsible for content aggregated from feed providers. Content provided by feed providers is the property of those feed providers. Contact their respective site owners for any questions.
Not responsible for content posted by users.
Stories posted on Philly Future *do not* represent the views of those volunteering to maintain it. If you disagree with a view or opinion shared here, please join the conversation. This is an open forum. If you see something illegal posted here let us know immediately.
Meta
GeoURL
This site made possible with software provided by Drupal.org.
Hosting provided by Firebright.
Content posted to Philly Future is licensed under a Creative Commons License.
Excess pharma profits from 'off label' promotion
My issue is Zyprexa which is only FDA approved for schizophrenia (.5-1% of pop) and some bipolar (2% pop) and then an even smaller percentage of theses two groups.
So how does Zyprexa get to be the 7th largest drug sale in the world?
Eli Lilly is in deep trouble for using their drug reps to 'encourage' doctors to write zyprexa for non-FDA approved 'off label' uses.
The drug causes increased diabetes risk,and medicare picks up all the expensive fallout.There are now 7 states (and counting) going after Lilly for fraud and restitution.
--
Daniel Haszard